A phase I study of VB6-845d
Phase of Trial: Phase I
Latest Information Update: 16 May 2018
At a glance
- Drugs Citatuzumab bogatox (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 16 May 2018 According to a Sesen Bio media release, Eleven Biotherapeutics changed its name to Sesen Bio.
- 23 Aug 2017 New trial record
- 14 Aug 2017 According to an Eleven Biotherapeutics media release, the company plans to file an investigational new drug (IND) application for VB6-845d and initiate a Phase 1 trial.